[The level of osteocalcin and bone mass in patients receiving anti-vitamin K agents].
Houvenagel
E
E
Service de Rhumatologie, Centre Hospitalier Saint-Philibert, Lomme-lès-Lille.
Leloire
O
O
Vanderlinden
T
T
Graux
P
P
Dutoit
A
A
Tison
F
F
Forzy
G
G
Racadot
A
A
Vincent
G
G
D000469:Alkaline Phosphatase / Q000032:analysis; D000925:Anticoagulants / Q000008:administration & dosage*; D015519:Bone Density; D002130:Calcium Phosphates / Q000032:analysis; D005272:Femur Neck; D006801:Humans; D006887:Hydroxycholecalciferols / Q000032:analysis; D008159:Lumbar Vertebrae; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000032:analysis*; D010281:Parathyroid Hormone / Q000032:analysis; D013997:Time Factors; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D002130:Calcium Phosphates; D006887:Hydroxycholecalciferols; D010281:Parathyroid Hormone; D015675:Osteocalcin; D014812:Vitamin K; D000469:Alkaline Phosphatase
Taux d'ostéocalcine et masse osseuse chez les patients recevant des antivitamines K.